vs

Side-by-side financial comparison of Strawberry Fields REIT, Inc. (STRW) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.

Strawberry Fields REIT, Inc. is the larger business by last-quarter revenue ($40.1M vs $20.6M, roughly 2.0× Entrada Therapeutics, Inc.). Strawberry Fields REIT, Inc. runs the higher net margin — 5.0% vs -84.4%, a 89.4% gap on every dollar of revenue. On growth, Strawberry Fields REIT, Inc. posted the faster year-over-year revenue change (31.5% vs -65.2%). Over the past eight quarters, Strawberry Fields REIT, Inc.'s revenue compounded faster (20.0% CAGR vs 6.4%).

Strawberry Fields REIT, Inc. is a real estate investment trust focused on healthcare-related real estate assets. It owns, operates and manages skilled nursing facilities, senior living communities, and medical office buildings, primarily serving markets across the United States for healthcare providers and elderly care operators.

Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.

STRW vs TRDA — Head-to-Head

Bigger by revenue
STRW
STRW
2.0× larger
STRW
$40.1M
$20.6M
TRDA
Growing faster (revenue YoY)
STRW
STRW
+96.7% gap
STRW
31.5%
-65.2%
TRDA
Higher net margin
STRW
STRW
89.4% more per $
STRW
5.0%
-84.4%
TRDA
Faster 2-yr revenue CAGR
STRW
STRW
Annualised
STRW
20.0%
6.4%
TRDA

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
STRW
STRW
TRDA
TRDA
Revenue
$40.1M
$20.6M
Net Profit
$2.0M
$-17.3M
Gross Margin
Operating Margin
52.4%
-106.0%
Net Margin
5.0%
-84.4%
Revenue YoY
31.5%
-65.2%
Net Profit YoY
37.6%
-173.8%
EPS (diluted)
$0.15
$-0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STRW
STRW
TRDA
TRDA
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$37.9M
Q1 25
$37.3M
$20.6M
Q4 24
$30.5M
$37.4M
Q3 24
$29.5M
$19.6M
Q2 24
$29.3M
$94.7M
Q1 24
$27.8M
$59.1M
Net Profit
STRW
STRW
TRDA
TRDA
Q4 25
$2.0M
Q3 25
$2.0M
Q2 25
$2.0M
Q1 25
$1.6M
$-17.3M
Q4 24
$1.5M
$1.1M
Q3 24
$944.0K
$-14.0M
Q2 24
$938.0K
$55.0M
Q1 24
$746.0K
$23.5M
Operating Margin
STRW
STRW
TRDA
TRDA
Q4 25
52.4%
Q3 25
56.6%
Q2 25
54.5%
Q1 25
54.1%
-106.0%
Q4 24
51.5%
-15.7%
Q3 24
54.4%
-110.7%
Q2 24
52.3%
56.4%
Q1 24
51.3%
35.7%
Net Margin
STRW
STRW
TRDA
TRDA
Q4 25
5.0%
Q3 25
5.1%
Q2 25
5.2%
Q1 25
4.2%
-84.4%
Q4 24
4.8%
3.0%
Q3 24
3.2%
-71.7%
Q2 24
3.2%
58.1%
Q1 24
2.7%
39.7%
EPS (diluted)
STRW
STRW
TRDA
TRDA
Q4 25
$0.15
Q3 25
$0.16
Q2 25
$0.16
Q1 25
$0.13
$-0.42
Q4 24
$0.17
$-0.20
Q3 24
$0.14
$-0.35
Q2 24
$0.14
$1.55
Q1 24
$0.12
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STRW
STRW
TRDA
TRDA
Cash + ST InvestmentsLiquidity on hand
$31.8M
$67.8M
Total DebtLower is stronger
$794.7M
Stockholders' EquityBook value
$12.1M
$417.3M
Total Assets
$885.2M
$486.5M
Debt / EquityLower = less leverage
65.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STRW
STRW
TRDA
TRDA
Q4 25
$31.8M
Q3 25
$19.8M
Q2 25
$96.3M
Q1 25
$42.3M
$67.8M
Q4 24
$48.4M
$101.2M
Q3 24
$29.3M
$78.0M
Q2 24
$16.1M
$185.3M
Q1 24
$15.1M
$68.4M
Total Debt
STRW
STRW
TRDA
TRDA
Q4 25
$794.7M
Q3 25
$779.4M
Q2 25
$794.1M
Q1 25
$715.5M
Q4 24
$673.9M
Q3 24
$584.5M
Q2 24
$555.0M
Q1 24
$560.4M
Stockholders' Equity
STRW
STRW
TRDA
TRDA
Q4 25
$12.1M
Q3 25
$14.2M
Q2 25
$15.5M
Q1 25
$19.6M
$417.3M
Q4 24
$18.2M
$428.7M
Q3 24
$12.6M
$422.4M
Q2 24
$7.4M
$429.9M
Q1 24
$7.5M
$269.4M
Total Assets
STRW
STRW
TRDA
TRDA
Q4 25
$885.2M
Q3 25
$880.6M
Q2 25
$897.3M
Q1 25
$834.8M
$486.5M
Q4 24
$787.6M
$526.3M
Q3 24
$661.5M
$554.6M
Q2 24
$635.9M
$582.0M
Q1 24
$634.9M
$510.8M
Debt / Equity
STRW
STRW
TRDA
TRDA
Q4 25
65.64×
Q3 25
54.70×
Q2 25
51.26×
Q1 25
36.47×
Q4 24
37.09×
Q3 24
46.34×
Q2 24
74.61×
Q1 24
74.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STRW
STRW
TRDA
TRDA
Operating Cash FlowLast quarter
$90.0M
$-38.5M
Free Cash FlowOCF − Capex
$-39.7M
FCF MarginFCF / Revenue
-192.9%
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
44.62×
TTM Free Cash FlowTrailing 4 quarters
$-58.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STRW
STRW
TRDA
TRDA
Q4 25
$90.0M
Q3 25
$20.7M
Q2 25
$29.8M
Q1 25
$19.0M
$-38.5M
Q4 24
$59.3M
$-31.6M
Q3 24
$11.8M
$-24.3M
Q2 24
$20.6M
$39.8M
Q1 24
$2.1M
$-25.5M
Free Cash Flow
STRW
STRW
TRDA
TRDA
Q4 25
Q3 25
Q2 25
Q1 25
$-39.7M
Q4 24
$-32.2M
Q3 24
$-24.9M
Q2 24
$38.8M
Q1 24
$-26.4M
FCF Margin
STRW
STRW
TRDA
TRDA
Q4 25
Q3 25
Q2 25
Q1 25
-192.9%
Q4 24
-86.2%
Q3 24
-127.3%
Q2 24
41.0%
Q1 24
-44.6%
Capex Intensity
STRW
STRW
TRDA
TRDA
Q4 25
Q3 25
Q2 25
Q1 25
5.6%
Q4 24
1.7%
Q3 24
3.3%
Q2 24
1.1%
Q1 24
1.4%
Cash Conversion
STRW
STRW
TRDA
TRDA
Q4 25
44.62×
Q3 25
10.26×
Q2 25
15.24×
Q1 25
11.97×
Q4 24
40.44×
-27.94×
Q3 24
12.53×
Q2 24
21.93×
0.72×
Q1 24
2.85×
-1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons